Willmen Youngsaye - Concepedia

Author

Willmen Youngsaye

Broad Institute

Also Known As

Amanda Hurley, Joseph Negri, W. Youngsaye, Willmen W. Youngsaye, Willmen Youngsaye, Youngsaye, Willmen

Publications

425

Citations

H-Index

Concepts

All Affiliations

Broad Institute Howard Hughes Medical Institute Whitehead Institute for Biomedical Research Massachusetts Institute of Technology Boston University

About

Willmen Youngsaye is an author at Broad Institute specializing in medicine, pharmacology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	183
2	Natural Sciences	3	3	161
3	Engineering	2	2	30
4	Health Sciences	1	1	19
5	Biochemistry	1	1	47

Willmen Youngsaye

Publications

409

Citations

H-Index

Page 1

	Year	Citations
Total Synthesis and Stereochemical Reassignment of (+)‐Neopeltolide Willmen Youngsaye, Jason T. Lowe, Frauke Pohlki, Angewandte Chemie International Edition Diversity Oriented SynthesisBioorganic ChemistryAbsolute ConfigurationNatural SciencesDiversity-oriented Synthesis	2007	106
Inhibiting mitochondrial phosphate transport as an unexploited antifungal strategy Catherine A. McLellan, Benjamin Vincent, Norma V. Solis, Nature Chemical Biology Antifungal AgentBiochemistryMitochondrial FunctionAntifungal AgentsMedicine	2017	47
Total Synthesis and Stereochemical Reassignment of (+)‐Neopeltolide Willmen Youngsaye, Jason T. Lowe, Frauke Pohlki, Angewandte Chemie	2007	41
Macrocyclic Hedgehog Pathway Inhibitors: Optimization of Cellular Activity and Mode of Action Studies Chris Dockendorff, M. Marek Nagiec, Michel Weïwer, ACS Medicinal Chemistry Letters Chemoprevention StrategyAction StudiesCellular PharmacologyPharmacotherapyPharmaceutical Chemistry	2012	40
Abstract 2644: AP32788, a potent, selective inhibitor of EGFR and HER2 oncogenic mutants, including exon 20 insertions, in preclinical models Francois Gonzalvez, Xiaotian Zhu, Wei‐Sheng Huang, Cancer Research Her2 VariantsHer2 Exon 20Molecular BiologyPathologyTumor Biology	2016	29
Optimization of PDE3A Modulators for SLFN12-Dependent Cancer Cell Killing Timothy A. Lewis, Luc de Waal, Xiaoyun Wu, ACS Medicinal Chemistry Letters	2019	28
Disrupting fluconazole resistance in Candida albicans clinical isolates with tetracyclic indoles Willmen Youngsaye, Chris Dockendorff, Benjamin Vincent, PubMed Central	2012	21
Discovery of mobocertinib, a potent, oral inhibitor of EGFR exon 20 insertion mutations in non–small cell lung cancer Wei‐Sheng Huang, Feng Li, Yongjin Gong, Bioorganic & Medicinal Chemistry Letters Egfr InhibitorsTumor BiologyOncologyAnti-cancer AgentRadiation Oncology	2022	21
Piperazinyl quinolines as chemosensitizers to increase fluconazole susceptibility of Candida albicans clinical isolates Willmen Youngsaye, Benjamin Vincent, Cathy L Hartland, Bioorganic & Medicinal Chemistry Letters Antifungal AgentHealth SciencesMedicineFluconazole SusceptibilityAntimicrobial Chemotherapy	2011	19
A Convenient Multigram Synthesis of Highly Enantioenriched Methyl 3-Silylglycidates Jason T. Lowe, Willmen Youngsaye, James S. Panek The Journal of Organic Chemistry Multigram Scale SynthesisEngineeringRacemic Cis-epoxysilaneOrganic ChemistrySynthetic Chemistry	2006	18

Page 1